修复时机紧迫性对钝性胸主动脉损伤胸主动脉腔内修复术后结局的影响
基于血管质量倡议注册数据,纳入2013至2022年因钝性胸主动脉损伤接受胸主动脉腔内修复术的患者(排除SVS 4级),比较紧急/急诊(≤24小时)与择期手术的结局。倾向评分加权后,择期与紧急/急诊手术的围手术期死亡率(3.9% vs 6.6%;OR 1.1;95%CI 0.27-4.7;P=0.90)和5年死亡率(5.8% vs 12%;HR 0.95;95%CI 0.21-4.3;P>0.9)无显著差异;择期手术与较低的术后卒中、拔管失败和肺炎相关。
要点
- 择期TEVAR与紧急/急诊TEVAR的围手术期死亡率和5年死亡率无显著差异。
- 择期TEVAR与较低的术后卒中(aOR 0.12)、拔管失败(aOR 0.18)和肺炎(aOR 0.34)相关。
- 择期TEVAR患者更可能接受左锁骨下动脉血运重建和术中肝素。
核心结论
- 择期与紧急/急诊TEVAR的围手术期死亡率和5年死亡率相似。
- 择期TEVAR与较低的术后缺血性卒中、肺部并发症和住院时间延长相关。
- 作者认为未来学会指南修订应纳入支持择期TEVAR用于BTAI的当前证据。
- 作者指出BTAI患者TEVAR的最佳时机及决定因素应成为未来研究主题,以促进个体化决策。
研究设计与样本
- 回顾性队列研究,使用血管质量倡议注册数据,纳入2013至2022年因钝性胸主动脉损伤接受TEVAR的患者,排除SVS 4级主动脉损伤。
- 共纳入1016例患者,其中102例(10%)接受择期TEVAR。
- 采用倾向评分逆概率加权逻辑回归和Cox回归评估围手术期结局和5年死亡率,并调整左锁骨下动脉血运重建/闭塞及年度中心和医生手术量。
主要发现
- 择期TEVAR患者更可能接受左锁骨下动脉血运重建(31% vs 7.5%;P<0.001)和术中肝素(94% vs 82%;P=0.002)。
- 逆概率加权后,择期与紧急/急诊TEVAR的围手术期死亡率无显著关联(3.9% vs 6.6%;OR 1.1;95%CI 0.27-4.7;P=0.90)。
- 逆概率加权后,择期与紧急/急诊TEVAR的5年死亡率无显著关联(5.8% vs 12%;HR 0.95;95%CI 0.21-4.3;P>0.9)。
- 择期TEVAR与较低的术后卒中相关(1.0% vs 2.1%;aOR 0.12;95%CI 0.02-0.94;P=0.044),调整术中肝素后仍显著(aOR 0.12;95%CI 0.02-0.92;P=0.042)。
- 择期TEVAR与较低的术后立即拔管失败(39% vs 65%;aOR 0.18;95%CI 0.09-0.35;P<0.001)和术后肺炎(4.9% vs 11%;aOR 0.34;95%CI 0.13-0.91;P=0.031)相关,但任何术后并发症复合结局和住院期间再干预的比值相当。
关键数值与推荐
- 择期TEVAR与紧急/急诊TEVAR的围手术期死亡率:3.9% vs 6.6%;OR 1.1;95%CI 0.27-4.7;P=0.90。
- 择期TEVAR与紧急/急诊TEVAR的5年死亡率:5.8% vs 12%;HR 0.95;95%CI 0.21-4.3;P>0.9。
- 择期TEVAR与紧急/急诊TEVAR的术后卒中:1.0% vs 2.1%;aOR 0.12;95%CI 0.02-0.94;P=0.044。
- 择期TEVAR与紧急/急诊TEVAR的术后立即拔管失败:39% vs 65%;aOR 0.18;95%CI 0.09-0.35;P<0.001。
- 择期TEVAR与紧急/急诊TEVAR的术后肺炎:4.9% vs 11%;aOR 0.34;95%CI 0.13-0.91;P=0.031。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current societal recommendations regarding the timing of thoracic endovascular aortic repair (TEVAR) for blunt thoracic aortic injury (BTAI) vary. Prior studies have shown that elective repair was associated with lower mortality after TEVAR for BTAI. However, these studies lacked data such as Society for Vascular Surgery (SVS) aortic injury grades and TEVAR-related postoperative outcomes. Therefore, we used the Vascular Quality Initiative registry, which includes relevant anatomic and outcome data, to examine the outcomes following urgent/emergent (≤ 24 hours) vs elective TEVAR for BTAI. METHODS: Patients undergoing TEVAR for BTAI between 2013 and 2022 were included, excluding those with SVS grade 4 aortic injuries. We included covariates such as age, sex, race, transfer status, body mass index, preoperative hemoglobin, comorbidities, medication use, SVS aortic injury grade, coexisting injuries, Glasgow Coma Scale, and prior aortic surgery in a regression model to compute propensity scores for assignment to urgent/emergent or elective TEVAR. Perioperative outcomes and 5-year mortality were evaluated using inverse probability-weighted logistic regression and Cox regression, also adjusting for left subclavian artery revascularization/occlusion and annual center and physician volumes. RESULTS: Of 1016 patients, 102 (10%) underwent elective TEVAR. Patients who underwent elective repair were more likely to undergo revascularization of the left subclavian artery (31% vs 7.5%; P < .001) and receive intraoperative heparin (94% vs 82%; P = .002). After inverse probability weighting, there was no association between TEVAR timing and perioperative mortality (elective vs urgent/emergent: 3.9% vs 6.6%; odds ratio [OR], 1.1; 95% confidence interval [CI], 0.27-4.7; P = .90) and 5-year mortality (5.8% vs 12%; hazard ratio [HR], 0.95; 95% CI, 0.21-4.3; P > .9).Compared with urgent/emergent TEVAR, elective repair was associated with lower postoperative stroke (1.0% vs 2.1%; adjusted OR [aOR], 0.12; 95% CI, 0.02-0.94; P = .044), even after adjusting for intraoperative heparin use (aOR, 0.12; 95% CI, 0.02-0.92; P = .042). Elective TEVAR was also associated with lower odds of failure of extubation immediately after surgery (39% vs 65%; aOR, 0.18; 95% CI, 0.09-0.35; P < .001) and postoperative pneumonia (4.9% vs 11%; aOR, 0.34; 95% CI, 0.13-0.91; P = .031), but comparable odds of any postoperative complication as a composite outcome and reintervention during index admission. CONCLUSIONS: Patients with BTAI who underwent elective TEVAR were more likely to receive intraoperative heparin. Perioperative mortality and 5-year mortality rates were similar between the elective and emergent/urgent TEVAR groups. Postoperatively, elective TEVAR was associated with lower ischemic stroke, pulmonary complications, and prolonged hospitalization. Future modifications in society guidelines should incorporate the current evidence supporting the use of elective TEVAR for BTAI. The optimal timing of TEVAR in patients with BTAI and the factors determining it should be the subject of future study to facilitate personalized decision-making.
引用
- Yadavalli SD, Summers SP, Rastogi V, et al. The impact of urgency of repair on outcomes following thoracic endovascular aortic repair for blunt thoracic aortic injury. J Vasc Surg. 2023. PMID: 38148614. doi:10.1016/j.jvs.2023.10.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。